104 related articles for article (PubMed ID: 9544663)
1. Direct detection of regional myocardial ischemia with technetium-99m nitroimidazole in rabbits.
Weinstein H; Reinhardt CP; Leppo JA
J Nucl Med; 1998 Apr; 39(4):598-607. PubMed ID: 9544663
[TBL] [Abstract][Full Text] [Related]
2. Ischemic and reperfused myocardium detected with technetium-99m-nitroimidazole.
Fukuchi K; Kusuoka H; Watanabe Y; Fujiwara T; Nishimura T
J Nucl Med; 1996 May; 37(5):761-6. PubMed ID: 8965142
[TBL] [Abstract][Full Text] [Related]
3. Delineation of the border zone of ischemic rabbit myocardium by a technetium-labeled nitroimidazole.
Di Rocco RJ; Bauer AA; Pirro JP; Kuczynski BL; Belnavis L; Chan YW; Linder KE; Narra RK; Nowotnik DP; Nunn AD
Nucl Med Biol; 1997 Apr; 24(3):201-7. PubMed ID: 9228654
[TBL] [Abstract][Full Text] [Related]
4. Myocardial kinetics of a putative hypoxic tissue marker, 99mTc-labeled nitroimidazole (BMS-181321), after regional ischemia and reperfusion.
Stone CK; Mulnix T; Nickles RJ; Renstrom B; Nellis SH; Liedtke AJ; Nunn AD; Kuczynski BL; Rumsey WL
Circulation; 1995 Sep; 92(5):1246-53. PubMed ID: 7648672
[TBL] [Abstract][Full Text] [Related]
5. Kinetic analysis of technetium-99m-labeled nitroimidazole (BMS-181321) as a tracer of myocardial hypoxia.
Ng CK; Sinusas AJ; Zaret BL; Soufer R
Circulation; 1995 Sep; 92(5):1261-8. PubMed ID: 7648674
[TBL] [Abstract][Full Text] [Related]
6. Technetium-99m-nitroimidazole (BMS181321): a positive imaging agent for detecting myocardial ischemia.
Shi CQ; Sinusas AJ; Dione DP; Singer MJ; Young LH; Heller EN; Rinker BD; Wackers FJ; Zaret BL
J Nucl Med; 1995 Jun; 36(6):1078-86. PubMed ID: 7769431
[TBL] [Abstract][Full Text] [Related]
7. Myocardial technetium-99m-teboroxime activity in acute coronary artery occlusion and reperfusion: relation to myocardial blood flow and viability.
Abraham SA; Mirecki FN; Levine D; Nunn AD; Strauss HW; Gewirtz H
J Nucl Med; 1995 Jun; 36(6):1062-8. PubMed ID: 7769429
[TBL] [Abstract][Full Text] [Related]
8. Myocardial uptake of thallium 201 and technetium 99m-labeled sestamibi after ischemia and reperfusion: comparison by quantitative dual-tracer autoradiography in rabbits.
Weinstein H; Reinhardt CP; Wironen JF; Leppo JA
J Nucl Cardiol; 1994; 1(4):351-64. PubMed ID: 9420718
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of a putative hypoxic tissue marker, technetium-99m-nitroimidazole (BMS181321), in normoxic, hypoxic, ischemic and stunned myocardium.
Kusuoka H; Hashimoto K; Fukuchi K; Nishimura T
J Nucl Med; 1994 Aug; 35(8):1371-6. PubMed ID: 8046496
[TBL] [Abstract][Full Text] [Related]
10. 99mTc-tetrofosmin assessment of myocardial perfusion and viability in canine models of coronary occlusion and reperfusion.
Glover DK; Ruiz M; Koplan BA; Watson DD; Beller GA
J Nucl Med; 1999 Jan; 40(1):142-9. PubMed ID: 9935070
[TBL] [Abstract][Full Text] [Related]
11. Technetium-99m-tetrofosmin to assess myocardial blood flow: experimental validation in an intact canine model of ischemia.
Sinusas AJ; Shi Q; Saltzberg MT; Vitols P; Jain D; Wackers FJ; Zaret BL
J Nucl Med; 1994 Apr; 35(4):664-71. PubMed ID: 8151391
[TBL] [Abstract][Full Text] [Related]
12. Myocardial uptake and kinetic properties of technetium-99m-Q3 in dogs.
Gerson MC; Millard RW; McGoron AJ; Gabel M; Washburn LC; Biniakiewicz D; Elder RC; Deutsch E; Walsh RA
J Nucl Med; 1994 Oct; 35(10):1698-706. PubMed ID: 7931674
[TBL] [Abstract][Full Text] [Related]
13. SPECT imaging of ischemic myocardium using a technetium-99m-nitroimidazole ligand.
Rumsey WL; Kuczynski B; Patel B; Bauer A; Narra RK; Eaton SM; Nunn AD; Strauss HW
J Nucl Med; 1995 Aug; 36(8):1445-50. PubMed ID: 7629592
[TBL] [Abstract][Full Text] [Related]
14. The potential for myocardial imaging with hypoxia markers.
Sinusas AJ
Semin Nucl Med; 1999 Oct; 29(4):330-8. PubMed ID: 10534235
[TBL] [Abstract][Full Text] [Related]
15. Effects of no flow and reperfusion on technetium-99m-Q12 kinetics.
Okada RD; Nguyen KN; Lauinger M; Allton IL; Spreitzer K; Beju D; Johnson G
J Nucl Med; 1995 Nov; 36(11):2103-9. PubMed ID: 7472606
[TBL] [Abstract][Full Text] [Related]
16. Flow versus uptake comparisons of thallium-201 with technetium-99m perfusion tracers in a canine model of myocardial ischemia.
Meleca MJ; McGoron AJ; Gerson MC; Millard RW; Gabel M; Biniakiewicz D; Roszell NJ; Walsh RA
J Nucl Med; 1997 Dec; 38(12):1847-56. PubMed ID: 9430457
[TBL] [Abstract][Full Text] [Related]
17. The relationship between myocardial retention of technetium-99m teboroxime and myocardial blood flow.
Beanlands R; Muzik O; Nguyen N; Petry N; Schwaiger M
J Am Coll Cardiol; 1992 Sep; 20(3):712-9. PubMed ID: 1512353
[TBL] [Abstract][Full Text] [Related]
18. 99mTcO(BAT-NI), a novel nitroimidazole tracer: in vivo uptake studies in ischaemic myocardium.
Hoffend J; Linke G; Mohammed A; Tiefenbacher CP; Eisenhut M; Haberkorn U
Eur J Nucl Med Mol Imaging; 2003 Apr; 30(4):494-501. PubMed ID: 12574972
[TBL] [Abstract][Full Text] [Related]
19. Technetium-99m-pyrophosphate uptake as an indicator of myocardial injury without infarct.
Okuda K; Nohara R; Fujita M; Tamaki N; Konishi J; Sasayama S
J Nucl Med; 1994 Aug; 35(8):1366-70. PubMed ID: 8046495
[TBL] [Abstract][Full Text] [Related]
20. Myocardial kinetics of Tc-99m glucarate in low flow, hypoxia, and aglycemia.
Okada DR; Johnson G; Liu Z; Hocherman SD; Khaw BA; Pak KY; Okada RD
J Nucl Cardiol; 2003; 10(2):168-76. PubMed ID: 12673182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
